March 16, 2020 / 9:59 PM / 16 days ago

BRIEF-Catalyst Pharmaceuticals Reports Q4 GAAP Earnings Per Share $0.07

March 16 (Reuters) - Catalyst Pharmaceuticals Inc:

* CATALYST PHARMACEUTICALS REPORTS FOURTH QUARTER AND YEAR-END 2019 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

* SEES FY 2020 REVENUE $135 MILLION TO $155 MILLION

* Q4 EARNINGS PER SHARE ESTIMATE $0.10 — REFINITIV IBES DATA

* REITERATES NET REVENUE GUIDANCE IN RANGE OF $135 MILLION TO $155 MILLION FOR FY 2020

* QTRLY REVENUES $30.1 MILLION VERSUS $500,000

* CATALYST PHARMACEUTICALS SAYS IN FACE OF CORONAVIRUS COVID-19 OUTBREAK, CO IS “WELL PREPARED & WELL-STOCKED” FOR ANY CONTINGENCIES Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below